What was recalled
The U.S. Food and Drug Administration (FDA) has issued a Class II recall involving specific batches of Levothyroxine Sodium Tablets, USP, manufactured by Accord Healthcare, Inc. This medication is widely used to treat hypothyroidism, a condition where the thyroid gland does not produce enough thyroid hormone. The products affected by this recall are packaged in two distinct formats: 90-count bottles and larger 1000-count bottles. The dosage strength for all recalled items is precisely 137 mcg (0.137 mg). It is important to note that these tablets are prescription-only medications, meaning they are dispensed directly to patients under the care of a medical professional.
The recall specifically targets two National Drug Code (NDC) numbers, which serve as unique identifiers for pharmaceutical products in the United States. The first category includes 90-count bottles identified by NDC 16729-454-15. The second category consists of 1000-count bottles, identified by NDC 16729-454-17. These codes are critical for pharmacists and healthcare providers to verify inventory, but they can also help patients identify their specific product if they check the labeling on their prescription bottle.
The affected items are linked to four specific lot numbers, which indicate the batch in which the drugs were manufactured. For the 90-count bottles (NDC 16729-454-15), the recalled lots are D2402125, D2402126, and D2402127. These batches were assigned an expiration date of September 30, 2026. For the 1000-count bottles (NDC 16729-454-17), the recalled lots are D2402523 and D2402524, with an expiration date of November 30, 2026. If you do not see these exact lot numbers on your bottle, your medication is likely not part of this recall.
Accord Healthcare, Inc., located in Raleigh, North Carolina, manufactured the product for which it is responsible, while the physical manufacturing took place at Intas Pharmaceuticals Limited in Selaqui, Dehradun, India. The distribution pattern for these recalled items was nationwide within the United States, meaning they could have been dispensed to patients in any state. The recall was officially initiated on August 6, 2026. Because this is a Class II recall, the FDA has determined that use of the product may cause temporary health problems or pose a slight threat of a serious nature, though it is not expected to cause serious adverse health consequences or death.
The hazard, explained
In this specific recall, Accord Healthcare, Inc. has identified a quality control issue with Levothyroxine Sodium Tablets, USP, 137 mcg. The official classification for this defect is a "subpotent drug." In plain terms, this means that the tablets in the affected lots contain less of the active ingredient than they are supposed to. While the medication is intended to deliver exactly 137 micrograms (0.137 mg) of levothyroxine sodium per pill to help regulate your metabolism, the recalled units fall short of this target. It is important to understand that "subpotent" does not mean the drug is inactive or completely useless; rather, it means the dosage is inconsistent and lower than what is printed on the label.
To understand why this matters, we need to look at how levothyroxine works in your body. Levothyroxine is a synthetic form of thyroxine (T4), a hormone that your thyroid gland naturally produces. This hormone acts as the master regulator for your metabolic rate, influencing how quickly your body burns calories, how fast your heart beats, and even how your brain functions. Unlike many other medications where missing a dose might have minor or delayed consequences, thyroid hormone replacement requires a very narrow therapeutic window. Your body relies on a precise balance of this hormone to function correctly. When the drug is subpotent, you are essentially receiving a lower dose than prescribed without realizing it.
The physical mechanism of harm here is subtle but significant. Because the active ingredient is deficient, your blood levels of thyroid hormone may drop below the optimal range, leading to a state known as hypothyroidism. This can happen gradually. You might not notice an immediate change after taking one or two pills, but over time, the cumulative effect of under-dosing can lead to a return of thyroid deficiency symptoms. These can include persistent fatigue, unexplained weight gain, sensitivity to cold, dry skin, hair loss, and difficulty concentrating. For many people, these symptoms are easily mistaken for stress, aging, or other common ailments, which can delay proper treatment.
The risk is particularly acute because levothyroxine is often prescribed for long-term, daily management of thyroid conditions. Patients who rely on this medication to maintain their metabolic health are essentially running a fine-tuned system. When the fuel (the hormone) is inconsistent or insufficient, that system begins to falter. While the FDA has classified this as a Class II recall—indicating that use of the product might cause temporary health problems or pose a slight threat of serious disease—the variability in potency means that some individuals may be affected more severely than others depending on their baseline health and sensitivity to thyroid fluctuations. The key takeaway is that the "subpotent" nature of this drug undermines the reliability of your treatment, making it impossible for you or your doctor to know if your symptoms are due to a disease progression or simply an incorrect dose.
Who is most at risk
The individuals who are primarily affected by this recall are those currently prescribed Levothyroxine Sodium Tablets, USP, specifically the 137 mcg (0.137 mg) strength manufactured by Accord Healthcare, Inc. Because this medication is classified as a prescription-only drug ("Rx Only"), the pool of potentially impacted users is defined strictly by their adherence to this specific prescription regimen. If you have been prescribed this exact dosage from this manufacturer within the affected lot numbers, you are part of the group that needs to take immediate action. It is important to note that individuals taking Levothyroxine from other manufacturers, different dosages, or over-the-counter supplements are not at risk from this specific recall event.
While anyone relying on these subpotent tablets faces health risks, certain populations are particularly vulnerable to the consequences of thyroid hormone deficiency. The most critical group includes patients with hypothyroidism who require precise hormonal balance for daily metabolic function. Levothyroxine is not a medication where minor fluctuations in dosage are easily tolerated. For these individuals, even a slight reduction in potency can lead to a gradual but significant drop in their metabolic rate. This can manifest as severe fatigue, weight gain, cold intolerance, and difficulty concentrating. For someone whose body has adjusted to a specific level of thyroid hormone, the sudden availability of less active medication can disrupt this delicate equilibrium, leading to a return of hypothyroid symptoms that can impact quality of life and daily functioning.
Elderly patients and those with pre-existing cardiovascular conditions face heightened risks. Thyroid hormone levels directly influence heart rate and cardiac output. In older adults, who may already have compromised heart health, the stress of untreated hypothyroidism can exacerbate underlying conditions such as high cholesterol or heart failure. The body’s inability to compensate for the lower hormone levels can place additional strain on the cardiovascular system. Furthermore, elderly individuals often take multiple medications, making it crucial to maintain strict adherence to their thyroid regimen to avoid complex drug interactions or compounded health issues.
Pregnant women and those planning to become pregnant are also in a high-risk category. Thyroid hormones are essential for fetal brain development, particularly during the first trimester. Even mild maternal hypothyroidism can have serious implications for fetal neurological development. Women in this demographic must ensure they are receiving fully potent medication to protect both their own health and the developing baby’s growth. Ignoring the subpotency of these recalled tablets could lead to unforeseen complications that are difficult to reverse once established.
Additionally, individuals with thyroid cancer who use Levothyroxine for suppression therapy are at risk. For these patients, maintaining a suppressed TSH (thyroid-stimulating hormone) level is a critical part of preventing cancer recurrence. Subpotent medication may fail to suppress TSH adequately, potentially allowing residual thyroid tissue or cancer cells to become active again. This makes the prompt identification and replacement of these recalled tablets especially urgent for oncology patients.
- Patients with confirmed hypothyroidism requiring stable hormone levels.
- Elderly individuals with cardiovascular vulnerabilities.
- Pregnant women or those planning pregnancy.
- Thyroid cancer patients on suppression therapy.
How to tell if you have the recalled item
Taking a moment to double-check your medication cabinet is one of the most sensible steps you can take right now. Because this recall involves Levothyroxine Sodium Tablets, USP, specifically those manufactured for Accord Healthcare, Inc., you need to look for several key details on your bottle’s label. The process is straightforward if you know exactly where to look and what specific numbers to verify. We will walk through this together so you can identify with confidence whether your supply is part of the affected batch.
First, locate the prescription bottle. You are looking for a product labeled as Levothyroxine Sodium Tablets, USP, with a strength of 137 mcg (which is equivalent to 0.137 mg). This specific dosage is critical because the recall does not apply to other strengths. Next, check the manufacturer information printed on the label. It should state that the product was manufactured for Accord Healthcare, Inc., located in Raleigh, NC 27617, and manufactured by Intas Pharmaceuticals Limited in Selaqui, Dehradun, India. If your bottle lists a different manufacturer or distributor, it is likely not part of this specific recall.
The most important step is verifying the National Drug Code (NDC) and the Lot Number. These are unique identifiers that determine if your specific unit is affected. You can find the NDC on the side or back of the bottle. For this recall, you must check for two specific codes:
- NDC 16729-454-15: This code corresponds to the 90-count bottles.
- NDC 16729-454-17: This code corresponds to the 1000-count bottles.
If your bottle has a different NDC, it is not included in this recall. Once you have confirmed the NDC, look for the Lot Number and the Expiration Date. These are usually printed together on the label. There are four specific lot numbers and two expiration dates to watch for:
- Lot Numbers D2402125, D2402126, or D2402127: These lots have an expiration date of 09/30/2026.
- Lot Numbers D2402523 or D2402524: These lots have an expiration date of 11/30/2026.
If your bottle does not match both the correct NDC and one of these specific lot numbers, you do not need to worry about this particular recall. It is also worth noting that this product was distributed nationwide within the United States, so the location where you purchased it does not determine whether it is recalled; only the printed codes matter. Take your time to read the label carefully. If you are unsure or cannot find the lot number clearly, do not hesitate to contact your pharmacist for assistance in verifying the details.
What to do — step by step
Because the recall notice from Accord Healthcare, Inc. does not explicitly state a specific remedy—such as a mandatory return for a refund, an authorized repair, or a direct replacement program—you must approach this situation with caution and prioritize your health safety above all else. Levothyroxine is a critical hormone replacement medication used to treat hypothyroidism, and receiving a subpotent version means you may not be getting the full therapeutic dose required to maintain your thyroid function. Therefore, your immediate actions should focus on preventing further exposure to the potentially ineffective medication and ensuring your medical care continues without interruption.
- Stop taking the recalled medication immediately. Do not wait for a specific instruction from the manufacturer or the FDA regarding disposal or return, as none is provided in this notice. Continuing to take Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg) from the affected lots could lead to a gradual decline in your thyroid hormone levels. This might result in symptoms such as fatigue, weight gain, sensitivity to cold, or irregular heartbeats. By stopping use now, you prevent any further accumulation of subpotent drug in your system.
- Contact your healthcare provider right away. This is the most important step in this process. Call your doctor or endocrinologist as soon as possible to inform them that you have been prescribed or are currently taking the recalled Accord Healthcare Levothyroxine. They need to know which specific lot numbers you were using (D2402125, D2402126, D2402127, D2402523, or D2402524) so they can assess your current health status. Your doctor may want to order thyroid function blood tests (TSH and Free T4 levels) to determine if the subpotent dosage has affected your hormone balance. They will also provide a new prescription for a different manufacturer’s Levothyroxine that is not part of this recall.
- Secure an alternative supply. Do not attempt to refill the prescription at your regular pharmacy with the same product, as they may still have stock from the affected lots. Instead, provide your doctor’s new prescription for a different brand or manufacturer to your pharmacist. Ask your pharmacist to verify that the new medication is not subject to any recalls. If you are running low on other medications, consider picking up a short-term supply of non-recalled thyroid medication if available, to bridge the gap until your insurance approves the new brand.
- Handle the recalled bottles safely. Since no return address or disposal instructions are listed in the FDA notice, do not mail the pills back to Accord Healthcare or Intas Pharmaceuticals unless you receive direct communication from them. You can typically dispose of unused medications by following local community drug take-back programs, which are often available at police stations, hospitals, or pharmacies. If no take-back program is available, mix the tablets with an unappealing substance like dirt, cat litter, or used coffee grounds in a sealed plastic bag before throwing them in your household trash to prevent accidental ingestion by children or pets.
- Monitor your body for changes. Over the next few weeks, pay close attention to how you feel. While one dose is unlikely to cause immediate harm, prolonged use of subpotent Levothyroxine can have cumulative effects. Keep a log of any symptoms like unusual tiredness, mood changes, or physical slowing. Share this log with your doctor during your follow-up appointment to help them adjust your treatment plan effectively.
If you encounter difficulties obtaining a replacement prescription or have questions about the safety of your current health status, you can contact the FDA MedWatch program for guidance on reporting adverse experiences or seeking further clarification. Always prioritize direct communication with your medical provider over waiting for manufacturer updates when dealing with critical life-sustaining medications.
Your refund, repair, or replacement options
When you receive a recall notice for a medication like Levothyroxine Sodium Tablets, the most immediate question is often, "What do I do with my money and my prescription?" In this specific instance involving Accord Healthcare, Inc., it is important to approach the situation with clarity and calm. The official FDA recall facts for this Class II hazard do not explicitly state a standard remedy such as a direct refund, a repair (which is generally not applicable to pharmaceuticals), or a replacement product from the manufacturer. This absence of a specified remedy in the public record does not mean you are left without options; rather, it means that the process relies heavily on established channels between pharmacies, distributors, and manufacturers.
First, understand that "subpotent" drugs do not typically require a physical repair. You cannot fix a tablet to make it potent again. Therefore, your primary action is to stop using the product immediately and return it to the point of purchase. If you filled this prescription at a retail pharmacy, contact them directly. Pharmacies have strict protocols for recalled medications. They will likely accept the unopened bottles back and coordinate with their wholesaler to issue a credit or refund to your account or insurance provider. This is the most common and efficient path for consumers. Do not throw the medication in the household trash unless explicitly instructed by the pharmacy, as improper disposal can be harmful to the environment.
If you are unsure about the status of your prescription or if you purchased the medication through a mail-order service, reach out to their customer care department immediately. Provide them with the lot numbers (D2402125, D2402126, D2402127, D2402523, or D2402524) and the expiration dates (09/30/2026 or 11/30/2026) found on the packaging. This information is critical for them to verify that your specific batch is part of this nationwide distribution recall. While the recall facts do not list a direct phone number for Accord Healthcare, Inc. in Raleigh, NC, or Intas Pharmaceuticals Limited in India, the pharmacy or distributor you bought from serves as your primary liaison. They have the contractual relationships necessary to process returns and refunds on your behalf.
In cases where the manufacturer or FDA does not specify a direct consumer hotline for financial restitution, the responsibility often falls to the supply chain partners. If your pharmacy cannot resolve the refund issue, you may need to contact Accord Healthcare, Inc.’s customer service directly. You can find their contact information on the product packaging or by visiting their official corporate website. Be prepared to provide detailed documentation, including your receipt, the NDC numbers (16729-454-15 for 90-count bottles or 16729-454-17 for 1000-count bottles), and clear photos of the lot number. This thoroughness ensures that any potential refund is processed accurately and quickly, protecting your financial interests while you prioritize your health by securing a new, safe supply of medication from your healthcare provider.
What can happen if you ignore it
When a medication like Levothyroxine Sodium is recalled for being subpotent, the immediate concern isn't usually a sudden reaction or an allergic response. Instead, the risk is quiet, cumulative, and physiological. Levothyroxine is not a pain reliever that wears off after a few hours; it is a hormone replacement therapy designed to maintain a very specific balance in your body. Your thyroid hormones regulate your metabolism, heart rate, body temperature, and energy levels. When the drug is subpotent, it means the tablets contain less of the active ingredient than they should—essentially, you are getting a weaker dose than prescribed.
If you continue to take these specific bottles without switching to a verified, non-recalled supply, your body will slowly drift back into a state of hypothyroidism. This is not a theoretical risk; it is the direct biological consequence of insufficient hormone levels. Because thyroid hormones have a relatively long half-life in the body, you might not feel different immediately after taking a weak pill. However, over weeks or months, the deficit adds up. You may begin to notice symptoms that mimic your original condition or indicate that your management plan has failed. These can include persistent fatigue that sleep does not fix, unexplained weight gain despite no changes in diet, sensitivity to cold when others are comfortable, dry skin, hair thinning, and a general sense of brain fog or difficulty concentrating.
The danger extends beyond how you feel day-to-day. For individuals with pre-existing heart conditions, the stakes are higher. Thyroid hormone levels directly influence heart function. While too much thyroid hormone can cause rapid heartbeat, too little can lead to an enlarged heart and elevated cholesterol levels over time. By unknowingly taking a subpotent version of your medication, you are allowing these risk factors to creep back up, potentially undoing months or years of cardiovascular management. There is also the risk of destabilizing other conditions that rely on metabolic stability, such as diabetes management, where thyroid status can influence blood sugar control.
Furthermore, ignoring this recall creates a gap in your medical care that is difficult to spot without blood work. You might assume you are still being treated effectively because you are adhering to your routine, but the treatment is effectively broken. This delay means you remain untreated for longer than necessary, prolonging the symptoms and potential health impacts. It is not about panic; it is about precision. Your body needs the exact amount of hormone prescribed by your doctor to function correctly. Taking a substitute that is under-dosed is like trying to fill a leaky bucket with a smaller hose—it simply cannot keep up with the demand.
- Persistent Fatigue: The most common early sign that thyroid levels are too low is exhaustion that does not improve with rest.
- Mood Changes: Untreated hypothyroidism can contribute to depression, anxiety, or irritability due to chemical imbalances in the brain.
- Metabolic Slowdown: Your body’s ability to burn calories and regulate temperature drops, leading to cold intolerance and weight fluctuations.
- Cardiovascular Strain: Long-term under-treatment can increase cholesterol levels and put additional stress on the heart muscle.
The good news is that these effects are generally reversible once proper dosing is restored. However, the longer you wait to address the subpotent supply, the longer your body remains in a state of imbalance. If you have been taking this medication for years, your body may have adjusted to your current (flawed) levels, and correcting it might require careful monitoring by your healthcare provider to avoid swinging too far in the other direction. Do not wait for symptoms to become severe to act. The goal is to maintain stability, and that requires a reliable source of medication.
Staying safe: broader tips
When you are managing a chronic health condition that requires daily medication like levothyroxine, your peace of mind comes from knowing exactly what is in your body and how it interacts with your system. Because thyroid hormones regulate your metabolism, heart rate, and energy levels, consistency is not just a preference—it is a medical necessity. One of the most effective ways to stay safe is to establish a routine that minimizes variables. This means taking your medication at the same time every day, ideally on an empty stomach as directed, and ensuring you are always using bottles from the same manufacturer if possible. While different manufacturers may have slightly different inactive ingredients, the active hormone must remain consistent in potency to keep your blood levels stable. If you ever receive a refill that looks different or has a different label than usual, do not hesitate to call your pharmacy to verify it before taking it.
Another critical layer of protection is becoming a proactive reader of safety notices. Government alerts like the one from the FDA are designed to catch issues early, but they rely on you to act on them. Make it a habit to check your medication bottles periodically, not just when you hear news about a recall. Look at the National Drug Code (NDC) and the lot number printed on the label. You can register your medications with the FDA’s Safety Reporting Portal or sign up for email alerts from the agency so that urgent notices land directly in your inbox rather than appearing as a headline you might miss while scrolling through social media. Being aware of the distribution patterns—such as knowing if a specific manufacturer supplies your local pharmacies—can also help you anticipate potential issues before they affect you personally.
Finally, maintain open and honest communication with your healthcare provider. If you notice any subtle changes in how you feel—such as unexplained fatigue, weight changes, or heart palpitations—these could be signs that your dosage needs adjustment, whether due to a recalled batch or natural changes in your body over time. Do not wait for your next scheduled appointment to report these symptoms. Your doctor may want to check your thyroid-stimulating hormone (TSH) levels sooner to ensure your treatment is working as intended. By combining vigilance with clear communication, you turn potential safety risks into manageable parts of your routine, ensuring that your health remains the priority without unnecessary anxiety.